Sfoglia per AUTORE
BUTI S
Collezione AO Ordine Mauriziano

  

Items : 34

Prognostic Impact of IMDC Category Shift From Baseline to Nivolumab Initiation in Metastatic Renal Cell Carcinoma: A Sub-Analysis of the MEET-URO 15 Study. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2025 Feb;23(1):102267. doi: 10.1016/j.clgc.2024.102267. Epub 2024 Nov 10.
2025
ASL Cuneo 2
AO Ordine Mauriziano

Puglisi S; Lipari H; Cavo A; Vignani F; Nolè F; Prati G; Morelli F; Spada M; Caffo O; Napoli MD; Atzori F; Malgeri A; Prati V; Sorarù M; Tudini M; Mollica V; Ricotta R; Baldessari C; Fratino L; Merler S; Procopio G; Naglieri E; Masini C; Zucali PA; Galli L; Sbrana A; Chiellino S; De Giorgi U; Maruzzo M; et alii...

Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study). in Future oncology (London, England) / Future Oncol. 2024 May 3:1-19. doi: 10.1080/14796694.2024.2340960.
2024
AO Ordine Mauriziano

Catalano F; Brunelli M; Signori A; Rescigno P; Buti S; Galli L; Spada M; Masini C; Galuppini F; Vellone VG; Gaggero G; Maruzzo M; Merler S; Vignani F; Cavo A; Bimbatti D; Milella M; Dei Tos AP; Sbaraglia M; Murianni V; Damassi A; Cremante M; Maffezzoli M; Llaja Obispo MA; Banna GL; Fornarini G; Rebuzzi SE;

Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Jun;22(3):102074. doi: 10.1016/j.clgc.2024.102074. Epub 2024 Mar 18.
2024
ASL Cuneo 2
AO Ordine Mauriziano

Cavo A; Bassanelli M; Formisano L; Mattana A; Marchetti A; Mennitto A; Di Napoli M; Pierantoni F; Grillone F; Vignani F; Calabrò F; Caffo O; Roviello G; Ermacora P; Iacovelli R; Vitale MG; Maiorano BA; Claps M; Bimbatti D; Maruzzo M; Massari F; Mollica V; Prati V; Giudice GC; Buti S;

Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2024 Jul 2;73(9):161. doi: 10.1007/s00262-024-03741-2.
2024
AO Ordine Mauriziano

Messina C; Catalano M; Roviello G; Gandini A; Maruzzo M; De Giorgi U; Pedrazzoli P; Sbrana A; Zucal PA; Masini C; Naglieri E; Procopio G; Milella M; Catalano F; Fratino L; Pipitone S; Ricotta R; Panni S; Mollica V; Soraru M; Prati V; Atzori F; Di Napoli M; Messina M; Morelli F; Prati G; Nole F; Malgeri A; Tudini M; et alii...

2024
AO Ordine Mauriziano

Fratino L; Polesel J; Giunta EF; Maruzzo M; Buti S; Hassan MA; Basso U; Rebuzzi SE; De Giorgi U; Cinausero M; Lipari H; Gamba T; Bimbatti D; Dri A; Ermacora P; Vignani F; Fornarini G; Rescigno P; Banna GL;

Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab. in Immunotherapy / Immunotherapy. 2024;16(18-19):1095-1103. doi: 10.1080/1750743X.2024.2385881. Epub 2024 Aug 19.
2024
ASL Cuneo 2
AO Ordine Mauriziano

Murianni V; Catalano F; Nolè F; Prati G; Morelli F; Messina M; Atzori F; Tudini M; Prati V; Roviello G; Cavo A; Vignani F; Caffo O; Napoli MD; Malgeri A; Rebuzzi SE; Signori A; Cremante M; Damassi A; Rescigno P; Banna GL; Fornarini G; Buti S;

Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study). in Future oncology (London, England) / Future Oncol. 2024;20(21):1495-1503. doi: 10.2217/fon-2023-1068. Epub 2024 Jun 12.
2024
AO Ordine Mauriziano

Catalano F; Brunelli M; Signori A; Rescigno P; Buti S; Galli L; Spada M; Masini C; Galuppini F; Vellone VG; Gaggero G; Maruzzo M; Merler S; Vignani F; Cavo A; Bimbatti D; Milella M; Dei Tos AP; Sbaraglia M; Murianni V; Damassi A; Cremante M; Maffezzoli M; Llaja Obispo MA; Banna GL; Fornarini G; Rebuzzi SE;

2024
ASL Cuneo 2
AO Ordine Mauriziano

Roviello G; Lipari H; Cavo A; Vignani F; Nolè F; Prati G; Morelli F; Spada M; Caffo O; Di Napoli M; Atzori F; Malgeri A; Prati V; Sorarù M; Tudini M; Mollica V; Ricotta R; Baldessari C; Fratino L; Milella M; Procopio G; Naglieri E; Masini C; Zucali PA; Galli L; Chiellino S; Bimbatti D; De Giorgi U; Rebuzzi SE; et alii...

Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study. in Frontiers in immunology / Front Immunol. 2024 Jul 5;15:1361010. doi: 10.3389/fimmu.2024.1361010. eCollection 2024.
2024
ASL Cuneo 2
AO Ordine Mauriziano

Naglieri E; Malgeri A; Cavo A; Di Napoli M; Vignani F; Nolè F; Prati G; Morelli F; Atzori F; Caffo O; Prati V; Fratino L; Tudini M; Mollica V; Sorarù M; Ricotta R; Pipitone S; Zampiva I; Chiellino S; Claps M; Fornarini G; Zucali PA; Galli L; Buti S; De Giorgi U; Maruzzo M; Rebuzzi SE; Catalano M; Signori A; et alii...

Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis. in iScience / iScience. 2023 Sep 22;26(11):107970. doi: 10.1016/j.isci.2023.107970. eCollection 2023 Nov 17.
2023
AO Ordine Mauriziano

Anpalakhan S; Signori A; Cortellini A; Verzoni E; Giusti R; Aprile G; Ermacora P; Catino A; Pipitone S; Di Napoli M; Scotti V; Mazzoni F; Guglielmini PF; Veccia A; Maruzzo M; Schinzari G; Casadei C; Grossi F; Rizzo M; Montesarchio V; Verderame F; Mencoboni M; Zustovich F; Fratino L; Accettura C; Cinieri S; Tondini CA; Camerini A; Banzi MC; et alii...

Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab. in JAMA network open / JAMA Netw Open. 2023 Nov 1;6(11):e2345185. doi: 10.1001/jamanetworkopen.2023.45185.
2023
AO Ordine Mauriziano

Catalano M; Rebuzzi SE; Maruzzo M; De Giorgi U; Buti S; Galli L; Fornarini G; Zucali PA; Procopio G; Chiellino S; Milella M; Catalano F; Pipitone S; Ricotta R; Sorarù M; Mollica V; Tudini M; Fratino L; Prati V; Caffo O; Atzori F; Morelli F; Prati G; Nolè F; Vignani F; Cavo A; Di Napoli M; Malgeri A; Naglieri E; et alii...

The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2023 Jun 26;31(7):425. doi: 10.1007/s00520-023-07867-4.
2023
AO Ordine Mauriziano

Giunta EF; De Padova S; Anpalakhan S; De Giorgi U; Maruzzo M; Rebuzzi SE; Cinausero M; Fratino L; Lipari H; Gamba T; Bimbatti D; Dri A; Ermacora P; Vignani F; Basso U; Buti S; Gandini A; Cremante M; Fornarini G; Rescigno P; Banna GL;

2023
AO Ordine Mauriziano

Bersanelli M; Verzoni E; Cortellini A; Giusti R; Calvetti L; Ermacora P; Di Napoli M; Catino A; Guadalupi V; Guaitoli G; Scotti V; Mazzoni F; Veccia A; Guglielmini PF; Perrone F; Maruzzo M; Rossi E; Casadei C; Montesarchio V; Grossi F; Rizzo M; Travagliato Liboria MG; Mencoboni M; Zustovich F; Fratino L; Accettura C; Cinieri S; Camerini A; Sorarù M; et alii...

2023
AO Ordine Mauriziano

Rebuzzi SE; Brunelli M; Galuppini F; Vellone VG; Signori A; Catalano F; Damassi A; Gaggero G; Rescigno P; Maruzzo M; Merler S; Vignani F; Cavo A; Basso U; Milella M; Panepinto O; Mencoboni M; Sbaraglia M; Dei Tos AP; Murianni V; Cremante M; Llaja Obispo MA; Maffezzoli M; Banna GL; Buti S; Fornarini G;

The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study. in Journal of translational medicine / J Transl Med. 2022 Sep 30;20(1):435. doi: 10.1186/s12967-022-03601-6.
2022
ASL Cuneo 2
AO Ordine Mauriziano

Messina M; Caffo O; Di Napoli M; Atzori F; Santini D; Soto Parra HJ; Prati V; Cortellini A; Santoni M; Sorarù M; Mollica V; Panni S; Ricotta R; Pipitone S; Fratino L; Boccardo F; Milella M; Procopio G; Naglieri E; Fantinel E; Zucali PA; Galli L; Chiellino S; Basso U; De Giorgi U; Maruzzo M; Damassi A; Fornarini G; Gandini A; et alii...

The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network. in Current oncology (Toronto, Ont.) / Curr Oncol. 2022 Oct 14;29(10):7745-7753. doi: 10.3390/curroncol29100612.
2022
AO Ordine Mauriziano

Banna GL; Basso U; Giunta EF; Fratino L; Rebuzzi SE; Buti S; Maruzzo M; De Giorgi U; Murianni V; Cinausero M; Lipari H; Gamba T; Caffo O; Bimbatti D; Dri A; Mosca A; Ermacora P; Vignani F; Msaki A; Bonifacio B; Lombardo V; Conteduca V; Fornarini G; Rescigno P;

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Russo A; Porzio G; Tiseo M; Russano M; Ficorella C; Addeo A; Banna GL; Friedlaender A; Spinelli GP; Metro G; Migliorino MR; Passiglia F; Ricciardi S; Zoratto F; Pecci F; Di Marino P; Mansueto G; De Tursi M; Tuzi A; Gori S; Della Gravara L; Macerelli M; Rastelli F; Chiari R; Gelibter A; Marchetti P; Antonuzzo L; Mazzoni F; et alii...

Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Jan;22(1):115-121. doi: 10.1080/14737140.2022.2002688. Epub 2021 No
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Procopio G; Verzoni E; De Braud FG; Pignata S; Ottini A; Guadalupi V; Claps M; Sepe P; Stellato M; Buttigliero C; Roviello G; Di Lorenzo G; Mucciarini C; Messina C; Sorarù M; Santini D; Casadei C; Buti S; De Giorgi U; Mennitto A; Zattarin E; Di Maio M; Bimbatti D;

Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysis. in Immunotherapy / Immunotherapy. 2022 Feb;14(2):145-153. doi: 10.2217/imt-2021-0157. Epub 2021 Nov 22.
2022
AO Ordine Mauriziano

Brunelli M; Cattrini C; Mazzaschi G; Bersanelli M; Buti S; Di Maio M;

2022
AO Ordine Mauriziano

Procopio G; Losanno T; Naglieri E; Stellato M; Tambaro R; Banna GL; Vignani F; De Giorgi U; Basso U; Maruzzo M; Farè E; Raggi D; Giannatempo P; Mazzaschi G; Bersanelli M; Pignata S; Necchi A; Buti S;

Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2022 Apr;20(2):155-164. doi: 10.1016/j.clgc.2021.12.008. Epub 2021 Dec 16.
2022
AO Ordine Mauriziano

Calabrò F; Losanno T; Caffo O; Veccia A; Roviello G; Vignani F; Santini D; Stellato M; Bersanelli M; Buti S; Naglieri E; Casadei C; De Giorgi U; Banna GL; Lipari H; Maruzzo M; Pierantoni F; Marandino L; Giannatempo P; Raggi D; Mucciarini C; Pignata S; Necchi A; Maio MD;

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2022 Apr;71(4):865-874. doi: 10.1007/s00262-021-03045-9. Epub 2021 Aug 31
2022
AO Ordine Mauriziano

Marconcini R; Intagliata S; Audisio M; Lai E; Aprile G; Buti S; Ghidini M; Macrini S; Inno A; Di Marino P; Tuzi A; Nicolardi L; Occhipinti MA; Pergolesi F; Veltri E; Adamo V; Filetti M; Ficorella C; Pantano F; Citarella F; Falcone A; Bossi P; Di Maio M; Scartozzi M; Di Noia V; Calvetti L; Bersanelli M; Grossi F; Gori S; et alii...

2022
ASL Cuneo 2
AO Ordine Mauriziano

Nolè F; Prati G; Morelli F; Messina M; Caffo O; Di Napoli M; Atzori F; Soto Parra HJ; Prati V; Cortellini A; Sorarù M; Santoni M; Massari F; Panni S; Ricotta R; Sabbatini R; Fratino L; Boccardo F; Milella M; Procopio G; Carella C; Fantinel E; Zucali PA; Galli L; Pedrazzoli P; De Giorgi U; Maruzzo M; Santini D; Stellato M; et alii...

Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Ficorella C; Addeo A; Friedlaender A; Banna GL; Di Maio M; Spinelli GP; Russo A; Adamo V; De Filippis M; Metro G; Simona C; Natalizio S; Migliorino MR; Landi L; Ricciardi S; Buti S; Minuti G; Nigro O; Cantini L; Bracarda S; Citarella F; Russano M; Filetti M; Zoratto F; Gori S; De Tursi M; Mansueto G; Rocco D; et alii...

Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7). in American journal of clinical oncology / Am J Clin Oncol. 2021 Mar 1;44(3):121-125. doi: 10.1097/COC.0000000000000791.
2021
AO Ordine Mauriziano

Mini E; Grillone F; Mucciarini C; Fornarini G; Soraru' M; Verzoni E; Sbrana A; Di Lorenzo G; De Vivo R; Bersanelli M; Buti S; Naglieri E; Bimbatti D; Maruzzo M; Casadei C; De Lisi D; Pantano F; De Giorgi U; Stellato M; Santini D; Vignani F; Attademo L; Pignata S; Procopio G;

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Cortellini A; Mazzaschi G; Tiseo M; Pinato DJ; Carmisciano L; Ficorella C; Porzio G; Cannita K; Friedlaender A; Addeo A; Banna GL; Spinelli GP; Adamo V; Russo A; Olmetto E; Metro G; Landi L; Ricciardi S; Migliorino MR; Tabbò F; Minuti G; Tuzi A; Bisonni R; Follador A; Gelibter A; Siringo M; Signorelli D; De Toma A; Garassino MC; et alii...

2021
AO Ordine Mauriziano

Mucciarini C; Vignani F; De Vivo R; Napolitano A; Buti S; Naglieri E; Di Lorenzo G; Soraru M; Sbrana A; Maruzzo M; Fornarini G; Casadei C; Pantano F; De Giorgi U; Verzoni E; Santini D; Stellato M; Grillone F; Roviello G; Di Napoli M; Procopio G;

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study). in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2021 May 18;13:17588359211019642. doi: 10.1177/17588359211019642. eCollection 20
2021
AO Ordine Mauriziano

Bersanelli M; Casadei C; Pierantoni F; Roviello G; Cavo A; Vignani F; Nolè F; Prati G; Morelli F; Messina C; Messina M; Pignata S; Atzori F; Stellato M; Soto Parra HJ; Prati V; Santoni M; Cortellini A; Sorarù M; Mollica V; Panni S; Ricotta R; Baldessari C; Fratino L; Tomasello L; Merler S; Procopio G; Naglieri E; Masini C; et alii...

Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study. in Immunotherapy / Immunotherapy. 2020 Feb;12(2):151-159. doi: 10.2217/imt-2019-0180.
2020
AO Ordine Mauriziano

Bersanelli M; Buti S; Banna GL; De Giorgi U; Cortellini A; Rebuzzi SE; Tiseo M; Fornarini G; Mazzoni F; Panni S; De Tursi M; Di Marino P; Rossetti S; Rossi E; Tomao S; De Luca E; Sorarù M; Mucciarini C; Atzori F; La Torre L; Vitale MG; Martelli V; Sepe P; Mollica V; Vaccaro V; Schinzari G; Ficorella C; Massari F; Maestri A; et alii...

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Dec;150:123-131. doi: 10.1016/j.lungcan.2020.10.008. Epub 2020 Oct 22.
2020
AO Ordine Mauriziano

Bersanelli M; Buti S; Giannarelli D; Leonetti A; Cortellini A; Russo GL; Signorelli D; Toschi L; Milella M; Pilotto S; Bria E; Proto C; Marinello A; Randon G; Rossi S; Vita E; Sartori G; D'Argento E; Qako E; Giaiacopi E; Ghilardi L; Bettini AC; Rapacchi E; Mazzoni F; Lavacchi D; Scotti V; Ciccone LP; De Tursi M; Di Marino P; et alii...

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Nov 2;12:1758835920968463. doi: 10.1177/1758835920968463. eCollection 2020.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Dicorato AM; Verusio C; Giordano P; Gernone A; Prati V; Carnio S; Corbo C; Tassinari D; Cavanna L; Meriggi F; Iannopollo M; Sartori D; Longo L; Pezzuolo D; Bonetti A; Mucciarini C; Bracarda S; Fornarini G; Battelli N; Russo A; Lacidogna G; Zucali PA; Sorarù M; Banzi M; Negrini G; Cinieri S; Fratino L; Zustovich F; Mencoboni M; et alii...

State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jul;139:87-90. doi: 10.1016/j.critrevonc.2019.05.003. Epub 2019 May 8.
2019
AO Ordine Mauriziano

Bersanelli M; Buti S; De Giorgi U; Di Maio M; Giannarelli D; Pignata S; Banna GL;

Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2019 Feb;17(1):e150-e155. doi: 10.1016/j.clgc.2018.10.001. Epub 2018 Oct 10.
2019
AO Ordine Mauriziano

Masini C; Vitale MG; Maruzzo M; Procopio G; de Giorgi U; Buti S; Rossetti S; Iacovelli R; Atzori F; Cosmai L; Vignani F; Prati G; Scagliarini S; Guida A; Berselli A; Pinto C;

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. in Immunotherapy / Immunotherapy. 2018 Oct;10(14):1229-1239. doi: 10.2217/imt-2018-0080.
2018
AO Ordine Mauriziano

Bersanelli M; Giannarelli D; Castrignanò P; Fornarini G; Panni S; Mazzoni F; Tiseo M; Rossetti S; Gambale E; Rossi E; Papa A; Cortellini A; Lolli C; Ratta R; Michiara M; Milella M; De Luca E; Sorarù M; Mucciarini C; Atzori F; Banna GL; La Torre L; Vitale MG; Massari F; Rebuzzi SE; Facchini G; Schinzari G; Tomao S; Bui S; et alii...